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Abstract
Background: Eimeria maxima is one of the most prevalent Eimeria species causing avian coccidiosis, and results in
huge economic loss to the global poultry industry. Current control strategies, such as anti-coccidial medication and
live vaccines have been limited because of their drawbacks. The third generation anticoccidial vaccines including
the recombinant vaccines as well as DNA vaccines have been suggested as a promising alternative strategy. To
date, only a few protective antigens of E. maxima have been reported. Hence, there is an urgent need to identify
novel protective antigens of E. maxima for the development of neotype anticoccidial vaccines.
Methods: With the aim of identifying novel protective genes of E. maxima, a cDNA expression library of E. maxima
sporozoites was constructed using Gateway technology. Subsequently, the cDNA expression library was divided
into 15 sub-libraries for cDNA expression library immunization (cDELI) using parasite challenged model in chickens.
Protective sub-libraries were selected for the next round of screening until individual protective clones were
obtained, which were further sequenced and analyzed.
Results: Adopting the Gateway technology, a high-quality entry library was constructed, containing 9.2 × 106 clones
with an average inserted fragments length of 1.63 kb. The expression library capacity was 2.32 × 107 colony-forming
units (cfu) with an average inserted fragments length of 1.64 Kb. The expression library was screened using parasite
challenged model in chickens. The screening yielded 6 immune protective genes including four novel protective
genes of EmJS-1, EmRP, EmHP-1 and EmHP-2, and two known protective genes of EmSAG and EmCKRS. EmJS-1 is
the selR domain-containing protein of E. maxima whose function is unknown. EmHP-1 and EmHP-2 are the
hypothetical proteins of E. maxima. EmRP and EmSAG are rhomboid-like protein and surface antigen glycoproteins
of E. maxima respectively, and involved in invasion of the parasite.
Conclusions: Our results provide a cDNA expression library for further screening of T cell stimulating or inhibiting
antigens of E. maxima. Moreover, our results provide six candidate protective antigens for developing new vaccines
against E. maxima.
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Background
Avian coccidiosis is the disease caused by protozoan para-
sites of the genus Eimeria [1, 2]. Eimeria maxima is one of
the seven Eimeria species that infects domestic chickens
and results in severe lesions of the small intestine, low effi-
ciency of feed utilization and weight loss [3, 4]. The global
economic losses due to avian coccidiosis are more than 3
billion US dollars per year [2, 5, 6]. Control strategies
against avian coccidiosis still rely heavily on anti-coccidial
medication and live vaccines [1, 4]. However, the applica-
tion of coccidiostats has been limited because of the rapid
emergence of drug resistance and increasing consumer
concerns about drug residues in food [7]. Live vaccines
have inherent drawbacks such as their limited production,
potential reversion to virulence and high cost of manufac-
ture [2, 6, 8]. The search for new approaches for coccidiosis
control turned towards third generation anticoccidial vac-
cines including recombinant vaccines as well as DNA vac-
cines [4, 6, 9–13]. To date, only a few protective antigens of
E. maxima have been reported. The lack of candidate pro-
tective antigens represents a considerable bottleneck in de-
veloping new vaccines against this parasite [14–16]. Hence,
finding novel protective antigens of E. maxima is urgently
required for the future development of univalent vaccines
and a multivalent vaccine to protect against infections with
multiple Eimeria species. With the aim of identifying novel
protective genes of E. maxima, in the present study, a
cDNA expression library of E. maxima sporozoites was
constructed using Gateway technology. Subsequently, the
protective genes of E. maxima were screened using cDELI
in parasite challenge model and the biological characters of
protective genes were analyzed.
Methods
Vector, parasite and animals
Eukaryotic expression vector pVAX1 was purchased from
Invitrogen (Carlsbad, California, USA). Sporulated oocysts
of E. maxima (Jiangsu) were collected 7 days prior to the
challenge infection. The purity of E. maxima was deter-
mined with ITS1-PCR as described previously [16, 17].
New-hatched Hy-Line layer chickens (commercial breed
W-36) were raised in a sterilized room under coccidia-free
conditions until the end of the experiment. Food and
water without anti-coccidial drugs were available.
RNA isolation for library construction
Sporozoites of E. maxima were purified from sporulated
oocysts on DE-52 anion exchange columns using a previ-
ously described protocol [18, 19]. Total RNA was ex-
tracted from E. maxima sporozoites using E.Z.N.A.® Total
RNA Kit Maxi Kit (OMEGA, Norcross, Georgia, USA).
Subsequently, mRNA was purified with FastTrack® MAG
mRNA Isolation Kits (Invitrogen). The quality of the
isolated total RNA and mRNA were determined by de-
naturing agarose gel electrophoresis.
Construction of cDNA entry library of E. maxima
The cDNA entry library was constructed using Clone-
Miner™ II cDNA Library Construction Kit (Invitrogen)
following manufacturer’s protocol (see Additional file 1:
Protocol for constructing entry library). To evaluate the
titer of cDNA entry library, 50 μl of the 1000-fold di-
luted library bacteria were cultured overnight at 37 °C
on LB plates containing100 μg/ml ampicillin. After that,
colonies on the plate were counted. The titer was calcu-
lated as follows: colony-forming units (cfu)/ml = colonies
on plate × dilution factor/volume plated (ml). Total cfu
of the library = titer (cfu/ml) × total volume of cDNA li-
brary (ml). To determine the insert size of the library, 24
random clones were amplified by PCR with universal
primers (5′-TCC CAG TCA CGA CGT TGT AAA ACG
ACG GCC AGT CTT-3′/5′-AGA GCT GCC AGG
AAA CAG CTA TGA CCA TGT AAT ACG ACT C-3′)
targeting the pDONR222 vector. The PCR program are
as following: 95 °C for 5 min with an initial denatur-
ation, 35 cycles of 94 °C for 30 s, 58 °C for 30 s and 72 °
C for 2 min, after 35 cycles, 72 °C for 5 min.
Construction of cDNA expression library for E. maxima
Prior to the construction of a cDNA expression library
for E. maxima, we ligated the recombinant gene attR1-
ccdB-attR2 into the expression vector pVAX1 to
construct a Gateway system compatible vector pVAX1-
DEST. Briefly, the attR1-ccdB-attR2 gene was amplified
from the pDEST32 vector (Invitrogen) by PCR using the
HindIII/XhoI-flanked primers (F/R 5′-GAC GAC AAG
CTT CTG TAT CGT CGA GGT CGA ATC AAA CAA
G-3′/5′-TCA TCC TCG AGT ACT TAC TTA GCG
GCC ATC AAA CCA C-3′, restriction enzyme of Hin-
dIII/XhoI are underlined). The PCR product was
digested with restriction enzymes HindIII/XhoI and
ligated into the pVAX1 vector to produce Gateway
system compatible vector pVAX1-DEST.
Afterwards, the LR recombination reaction was per-
formed to transfer the cDNA entry library into the
expression vector pVAX1-DEST using CloneMiner™ II
cDNA Library Construction Kit (Invitrogen). The reac-
tion products were transformed into ElectroMAX™
DH10B™ T1 competent cells, producing the cDNA ex-
pression library. The cDNA library titer was determined
using plating assay described in entry library construc-
tion. The similar PCR detection of recombinant frag-
ment size was performed with primers (CMV-F, 5′-CGC
AAA TGG GCG GTA GGC GTG-3′ and BGH, 5′-TGG
CAA CTA GAA GGC ACA GTC GAG G-3′) of
pVAX1-DEST vector.
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Test of the cDNA expression library by PCR amplification
of known E. maxima genes
To test the representativeness of the cDNA expression
library, 7 available E. maxima genes in our lab were
amplified from the constructed cDNA expression library
of E. maxima. Briefly, 10 μl of the cDNA expression
library was inoculated into 5 ml of broth culture
medium which was grown to an OD600 of 1, before the
plasmid DNA was isolated from the culture. With the
isolated DNA as template, the E. maxima genes of
MIC3-1, MIC3-2, MIC3-3, MIC2, MIC7, MIC5 and
AMA1 were amplified by PCR using specific primers
(see Additional file 2: Table S1). The PCR products were
analysed by 1% agarose gel electrophoresis.
The first round of cDNA expression library screening
Preparation of plasmid DNA for library screening
Ten microlitres of the cDNA expression library was
divided into 15 first-level sub-libraries and plasmid DNA
was isolated from each of the sub-libraries for screening.
Briefly, 10 μl of cDNA expression library was diluted
into 3 ml of LB broth and plated onto 15 LB agar plates
(each plate representing an individual sub-library) con-
taining 50 μg/ml kanamycin (200 μl of each plate). Next,
the plates were incubated at 37 °C for 16–18 h. All
resulting clones were then transferred into 150 ml broth
culture medium and incubated at 30 °C for 16–18 h.
Plasmid DNA was then isolated from each sub-library
using a High Pure Maxi Plasmid Kit (TIANGEN, Beijing,
China) following manufacturer’s instructions. Mean-
while, the plasmid DNA of empty vector pVAX1 was
prepared. The concentration of the plasmid DNA was
measured by NanoDrop 2000 spectrophotometer and
stored at -20 °C for further use.
Immunization and challenge infection
At 14 days of age, 360 chickens were weighed individu-
ally and randomly distributed into 15 experimental
groups and 3 control groups of 20 chickens in each. As
shown in Table 1, the experimental groups were the 15
sub-library immunized groups, the 3 control groups
were pVAX1 vector control, unchallenged control and
challenged control group. Experimental groups were
immunized with library plasmid DNA by intramuscular
injection in legs at a dose of 100 μg. The vector control
group was immunized with 100 μg of vector pVAX1,
whereas the challenged and unchallenged controls were
injected with PBS. A booster immunization was given by
the same method as the primary immunization 7 days
later. After 1 week of booster immunization, chickens
were weighed individually and challenged orally with
1.5 × 105 E. maxima oocysts except the unchallenged
control group. The chickens were weighed individually
and sacrificed by cervical dislocation 7 days post-chal-
lenge. Average body-weight gain, survival rate, decreased
oocyst output, lesion score, and anticoccidial index










Unchallenged control 86.59 ± 18.89f 100 0 ± 0a 100 200
Challenged control 23.50 ± 13.29a 25.14 3.10 ± 0.27f 0 54.14
pVAX1 control 26.26 ± 10.90ab 27.88 2.50 ± 0.31e 6.28 62.88
Pool 1 41.67 ± 15.75bcd 47.16 1.43 ± 0.40ab 49.54 127.79
Pool 2 69.50 ± 25.85ef 79.37 1.45 ± 0.45ab 60.27 154.79
Pool 3 80.57 ± 12.85f 90.80 1.22 ± 0.46a 70.57 168.57
Pool 4 58.81 ± 18.80de 66.06 2.40 ± 0.47de 57.16 137.06
Pool 5 56.90 ± 15.33cde 64.60 2.00 ± 0.57cde 53.00 139.6
Pool 6 59.38 ± 19.75de 65.99 1.94 ± 0.68cd 66.55 141.55
Pool 7 82.49 ± 25.46f 89.23 1.30 ± 0.59ab 68.67 171.16
Pool 8 77.67 ± 20.64f 85.52 1.22 ± 0.48a 74.59 168.27
Pool 9 49.66 ± 9.97cd 52.67 1.42 ± 0.53ab 62.03 133.39
Pool 10 57.73 ± 20.12de 65.38 2.40 ± 0.45de 54.27 136.38
Pool 11 40.60 ± 21.94abc 46.85 1.75 ± 0.51bc 46.37 124.35
Pool 12 58.89 ± 21.98de 64.64 2.10 ± 0.39cde 51.96 138.64
Pool 13 24.93 ± 11.20ab 26.88 2.48 ± 0.60e 15.53 97.07
Pool 14 58.70 ± 22.94de 63.45 2.12 ± 0.52cde 50.812 137.2
Pool 15 31.68 ± 9.17ab 36.41 1.42 ± 0.67ab 40.37 117.18
Note: Significant difference (P < 0.05) between numbers with different letters; non-significant difference (P > 0.05) between numbers with the same letter
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(ACI) of each group were calculated as described in the
evaluation of protection.
Evaluation of protection
Several criteria were employed for evaluating the efficacy
of DNA immunization with the expression library
including survival rate, lesion score, body-weight gain,
decreased oocyst output and ACI. The equations for cal-
culating the criteria were shown in Additional file 3:
Equations of criteria for evaluating the efficacy of DNA
immunization with the expression library. Any sub-li-
brary with the ACI ≥ 160 was considered protective [20,
21]. Body-weight gain and lesion scores were expressed
as the mean ± standard deviation (SD) and statistical
analysis was performed using the SPSS statistical pack-
age (IBM SPSS Statistics 19). Differences between
groups were tested with the one-way ANOVA Duncan
test and were considered significant at P < 0.05.
The further rounds screening of the individual protective
clone
The second round screening was performed according to
the result of the first round screening. Briefly, the protect-
ive first-level sub-library was divided into several second-
level sub-libraries. The immunization and challenge
experiment was carried out to determine the protective
second-level sub-library. The experimental design and
efficacy evaluation was same as the first round screening.
A third, fourth and even fifth round of screening was
performed until the individual protective clone was
obtained, following the experimental design and efficacy
evaluation described in the first round screening.
DNA sequencing and sequence analysis
The protective clones were sequenced by Invitrogen Com-
pany (Shanghai, China). The open reading frame (ORF) of
the protective antigen genes was determined with DNAS-
TAR software and ORF Finder (https://www.ncbi.nlm.-
nih.gov/orffinder/). The ORF and predicted protein
sequence of the antigen gene was blasted with NCBI (the
National Center for Biotechnology Information, https://
blast.ncbi.nlm.nih.gov/Blast.cgi) and ToxoDB database
(www.toxodb.org). The T cell epitope motif and antigen
index were predicted using DNASTAR software.
Results
Construction of E. maxima cDNA expression library
Our study adopted Gateway technology for library con-
struction with the modified pVAX1 vector. Figure 1a
shows sporulated oocysts of E. maxima. The integrity
and purity of total RNA extracted from the sporozoites
were detected by 1% denaturing agarose gel electrophor-
esis (Fig. 1b, Lane 1) and nucleic acid analyzer (Thermo
nanodrop) and purified mRNA were performed for the
same analysis (Fig. 1b, Lane 2). As shown in Fig. 1b
(Lane 1), electrophoresis clearly revealed 3 bands of 28S,
18S, and 5S of total RNA. Furthermore, the brightness
of 28 s was about 2 times of 18 s, which indicated good
integrity of the total RNA (Fig. 1b, Lane 2). The quantity
of the total RNA was about 600 μg and the A260/A280
value at 1.92, which indicated good purity of the total
RNA. The purified mRNA appeared excellent quality
with an A260/A280 value of 2.32, whereas the total
mRNA quantity was approximately 8.83 μg.
The cDNA entry library titer was determined by serial
dilution using plating assay. After growing overnight,
230 clones were counted on the plate (Fig. 1c). Accord-
ing to the equations, the titer of the plate was calculated
as 4.6 × 106 cfu, and the total clones of the entry were
9.2 × 106. Insert size of the library was detected by PCR,
and the positive bands were generated from all the ran-
domly picked 24 clones. Furthermore, the insert size
ranged from 0.9 to 2.8 Kb with an average size of 1.63
Kb (Fig. 1c). These data indicated that the entry library
was well represented and could be applied further for
the construction of expression library. The cDNA
expression library was evaluated in the same way. The
results showed that the expression library capacity was
2.32 × 107 cfu. The length of insert was ranged from 1 to
3 Kb with an average size of 1.64 Kb (Fig. 1d).
Test of the cDNA expression library by PCR amplification
of known E. maxima genes
To test the representativeness of the cDNA expression
library, 7 E. maxima genes with different sizes were
amplified from the expression library. As showed in
Fig. 1e, PCR revealed 7 bands of 450, 684, 336, 1275,
519, 888 and 1422 bp. The bands were consistent with
the sizes of E. maxima genes MIC3-1, MIC3-2, MIC3-3,
MIC2, MIC7, MIC5 and AMA1, respectively.
Screening of cDNA expression library
The first round screening
The cDNA expression library was partitioned into 15
sub-libraries (termed pool 1–15) with 200–300 clones
per pool. Two-week-old chickens were immunized with
the isolated plasmid DNA of the 15 sub-libraries to
compare their protective efficacies. As shown in Table 1,
except pool 13, immunization with the other 14 pools
resulted in alleviated enteric lesion, higher weight gain
and decreased oocyst output as compared to the pVAX1
vector control group and challenged control group.
Pools 3, 7 and 8 induced the highest decreased oocyst
output of 70.57, 68.67 and 74.59%, which resulted in
ACIs of 168.57, 171.16 and 168.27, respectively, indicat-
ing effective protection. The combined results indicated
that pool 3, 7 and 8 were the protective pools and could
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be selected for the second round screening of protective
clones.
The second round screening
Since pool 3, 7 and 8 were the most protective, emphasis
was given to identifying the protective component(s) in
these pools. As shown in (Table 2), pool 3, 7 and 8 were
partitioned into 4 second-level sub-libraries respectively
(designated pool 3–1 to 3–4, pool 7–1 to 7–4, pool 8–1
to 8–4) with 50–75 clones per pool. Animal experiments
were performed to compare the protective efficacy of
the second-level sub-libraries following the experimental
design described as the first round screening. The results
were shown in Table 2. Pool 8–2 induced the highest de-
creased oocyst output and ACI of 172.27, indicating that
it could be selected for the third round screening of
protective clones.
The third round screening
The protective pool 8–2 (63 clones) was partitioned into
9 third-level sub-libraries (designated pool 8–2–1 to 8–
2–9) with 7 clones per pool. The results of protective
efficacies of each clone were shown in (Table 3). Pool 8–
2–2 and 8–2–8 induced the ACIs of 164.54 and 163.43,
respectively, indicating that pool 8–2–2 and 8–2–8
could be selected for the fourth round screening of pro-
tective individual clones.
The fourth round screening
All the individual clones from the two positive pools
(pool 8–2–2 and 8–2–8) were designated as clone 8–2–
2–1 to 8–2–2–7 and 8–2–8–1 to 8–2–8–7 respectively
(Table 4). The results of protective efficacies of the 14
single clones were shown in Table 4. Six individual
clones induced ACIs > 160 namely, 8–2–2–2 (162.97),
8–2–2–5 (167.21), 8–2–8–1 (162.22), 8–2–8–2 (160.02),
8–2–8–3 (160.02) and 8–2–8–6 (160.74).
DNA sequence analysis
After four rounds screening, 6 individual protective
clones were identified. The positive clone 8–2–2–2
shared 76% identity in amino acids with hypothetical
protein of E. maxima (GenBank: CDJ56976.1) and was
named as EmHP-1. The positive clone 8–2–2–5 shared
Fig. 1 Construction procedure of E. maxima cDNA expression library. a Sporulated oocyst of E. maxima. Scale-bar: 10 μm. b Quality determination of
the isolated total RNA and mRNA of E. maxima by denaturing agarose gel electrophoresis. c Titer and insert size evaluation of the entry library using
plating assay and PCR assay. d Titer and insert size evaluation of the cDNA expression library using plating assay and PCR assay. e Amplification of 7
known genes from the cDNA expression library
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100% identity in amino acids with SAG family member
of E. maxima (GenBank: CDJ60815.1) and was named
as EmSAG. The positive clone 8–2–8–1 shared 91 and
84% identity in amino acids with Eimeria tenella
rhomboid-like protein (GenBank: ABC50099.1) and E.
maxima rhomboid family domain-containing protein,
putative (GenBank: CDJ59262.1) respectively, and was
named as EmRP. The positive clone 8–2–8–2 shared
70% identity in amino acids with E. maxima hypo-
thetical protein (GenBank: CDJ61108.1) and was
named as EmHP-2. The positive clone 8–2–8–3
shared 100% identity in amino acids with Eimeria
maxima CAMP-dependent protein kinase regulatory
subunit (GenBank: CDJ61187.1) and was named as
EmCKRS. The positive clone 8–2–8–6, named as
EmJS-1, shared 79% identity in amino acids with
hypothetical protein of Eimeria_necatrix_Houghton
(ToxoDB: ENH_00014740) and no identity with the
known gene of E. maxima.
Characterizations of these 6 protective clones were
shown in (Table 5). Complete ORFs were included
within the 6 antigen genes separately (Table 5,
Additional file 4: Figure S1). Prediction of T cell epitope
motif and antigen index revealed that the identified anti-
gens are abundant in T cell epitope motifs and regions
with high antigenic index (Table 5, Additional file 5:










Unchallenged control 79.97 ± 18.85f 100 0 ± 0a 100 200
Challenged control 54.34 ± 20.57bc 68.40 2.61 ± 0.37h 0 102.23
pVAX1 control 52.80 ± 19.10ab 71.04 1.65 ± 0.64bcd 12.50 114.46
Pool 3–1 42.06 ± 23.21a 52.88 2.25 ± 0.55fg 51.39 120.38
Pool 3–2 48.79 ± 22.91a 63.82 2.50 ± 0.76gh 31.11 128.82
Pool 3–3 47.96 ± 22.10ab 61.75 1.85 ± 0.36cde 51.39 133.25
Pool 3–4 42.81 ± 36.90ab 54.88 2.20 ± 0.57f 40.56 127.88
Pool 7–1 60.47 ± 28.12cd 79.86 1.50 ± 0.48b 36.11 144.86
Pool 7–2 54.49 ± 30.97bc 69.62 1.57 ± 0.70bc 69.44 143.85
Pool 7–3 60.14 ± 16.57cd 79.75 1.93 ± 0.45cde 70.83 150.42
Pool 7–4 60.58 ± 21.90cd 82.32 1.64 ± 0.49bcd 52.78 155.85
Pool 8–1 64.21 ± 15.77de 82.55 1.63 ± 0.61bcd 50.00 156.22
Pool 8–2 76.23 ± 18.14ef 94.77 1.75 ± 0.54bcde 88.89 172.27
Pool 8–3 60.58 ± 19.20cd 81.82 2.00 ± 0.44def 31.94 141.82
Pool 8–4 69.19 ± 21.47def 83.58 2.05 ± 0.34e 56.94 152.99
Note: Significant difference (P < 0.05) between numbers with different letters; non-significant difference (P > 0.05) between numbers with the same letter










Unchallenged control 98.26 ± 13.09e 100 0 ± 0a 100.00 200
Challenged control 37.72 ± 41.47a 40.91 3.05 ± 0.84f 0.00 70.41
pVAX1 control 41.47 ± 27.85ab 43.81 2.60 ± 1.16e 17.95 77.81
Pool 8–2–1 41.98 ± 26.55ab 45.34 2.00 ± 1.19d 75.64 120.34
Pool 8–2–2 79.85 ± 40.00d 84.74 1.02 ± 1.25b 61.54 164.54
Pool 8–2–3 54.62 ± 42.72bc 59.28 2.12 ± 1.17d 65.38 128.08
Pool 8–2–4 44.65 ± 30.68ab 46.35 2.30 ± 1.12de 71.79 113.35
Pool 8–2–5 43.87 ± 28.02ab 47.15 1.37 ± 1.07bc 43.59 113.45
Pool 8–2–6 51.47 ± 25.97bc 55.58 2.10 ± 1.29d 62.82 124.58
Pool 8–2–7 55.07 ± 26.63c 56.80 2.32 ± 1.09de 64.10 123.6
Pool 8–2–8 73.93 ± 30.41d 82.93 1.45 ± 1.35c 84.62 163.43
Pool 8–2–9 45.56 ± 38.25abc 50.20 2.55 ± 0.95e 62.82 114.7
Note: Significant difference (P < 0.05) between numbers with different letters; non-significant difference (P > 0.05) between numbers with the same letter
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Unchallenged control 57.61 ± 9.47f 100 0 ± 0a 100.00 200
Challenged control 36.89 ± 11.89ab 63.68 2.63 ± 0.63fg 0.00 97.30
pVAX1 control 37.42 ± 6.82abc 60.29 1.80 ± 0.38cdef 8.91 102.24
Clone 8–2–2–1 41.76 ± 18.49abcde 69.09 2.81 ± 1.50g 56.44 130.97
Clone 8–2–2–2 48.83 ± 12.79cdef 81.12 0.81 ± 0.62b 51.49 162.97
Clone 8–2–2–3 40.12 ± 13.95abcd 64.47 2.36 ± 1.24defg 13.86 100.79
Clone 8–2–2–4 43.26 ± 14.30abcde 73.50 2.84 ± 1.21g 14.85 105.08
Clone 8–2–2–5 56.63 ± 26.03f 93.89 1.66 ± 0.93bcde 56.44 167.21
Clone 8–2–2–6 38.82 ± 11.68abcd 63.52 1.92 ± 1.32cdef 23.76 104.31
Clone 8–2–2–7 39.88 ± 18.61abcd 66.43 2.78 ± 1.42g 18.81 98.54
Clone 8–2–8–1 50.04 ± 19.32def 84.86 1.26 ± 0.92bc 52.48 162.22
Clone 8–2–8–2 48.27 ± 16.57bcdef 80.03 1.50 ± 1.31bcd 82.18 160.02
Clone 8–2–8–3 49.52 ± 18.54def 85.80 1.57 ± 1.75bcd 72.28 160.02
Clone 8–2–8–4 34.84 ± 14.24a 60.28 1.52 ± 1.24bcd 15.84 105.02
Clone 8–2–8–5 46.87 ± 12.41bcdef 82.19 1.47 ± 1.19bc 66.34 157.46
Clone 8–2–8–6 52.41 ± 15.10ef 89.07 1.83 ± 1.24cdef 60.40 160.74
Clone 8–2–8–7 39.89 ± 11.89abcd 68.08 2.46 ± 1.14efg 35.64 123.40
Note: Significant difference (P < 0.05) between numbers with different letters; non-significant difference (P > 0.05) between numbers with the same letter

























8–2–2–5 EmSAG 1076 708 24.73 4.81 22–25, 39–42, 45–48, 63–66, 79–








8–2–8–1 EmRP 1004 774 28.34 8.27 8–11, 19–22, 60–64, 66–70, 90–







8–2–8–2 EmHP–2 1261 753 27.91 5.01 29–32, 114–118, 133–139, 149–
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Figure S2). EmHP-1, EmRP, EmHP-2 and EmJS-1 are
novel genes of E. maxima, their nucleotide sequences
and amino acids have been submitted to GenBank with
the accession numbers of KR868754.1, KR815509,
KR868755.1 and KR868753.1, respectively (Table 5).
Discussion
The expression library immunization (ELI) has proven
to be a useful strategy to identifying protective gene
pools for novel vaccine candidates, even when little is
known about the possible antigenic targets [22, 23]. The
cDELI, based on a large number of cDNA clones, has
additional advantages over genomic immunization
approaches, because a cDNA expression library repre-
sents only those genes that are being expressed and the
selection of stage-specific antigens is possible. The use
of cDELI could be particularly attractive for pathogens
with complicated life-cycles and large genomes [24]. To
date, cDELI has discovered protective genes or gene
pools from a diverse set of bacterial, fungal, and parasitic
pathogens [23–27]. In this research, we used cDELI to
screen the protective genes of E. maxima and success-
fully obtained six protective genes.
As effective protection is the key characteristic of a
practical vaccine, ELI was originally designed with the
intention of using actual pathogen challenge as the
screening criterion [22, 23]. In this study, we screened
the protective genes using actual parasite challenge
model in chickens and the six screened genes did pro-
vide effective protection against E. maxima. The DNA
sequence analysis revealed that the six genes are abun-
dant in predicted T cell epitope motifs and regions with
high antigenic index. In our subsequent study, we
immunized chickens with the identified genes and evalu-
ated the level of cytokines, T cell subtype and IgG of the
immunized chickens. The results revealed that the
immunization with the genes induced significantly en-
hanced T cell response and antibodies in the immunized
chickens (unpublished data), compared with the control
chickens, which are consistent with the DNA sequence
analysis and the effective protection of these genes.
In the current study, only six protective genes were
obtained through cDELI. The number of protective
genes isolated through cDELI was also limited in previ-
ous studies. For example, Ivey et al. [25] isolated only
one protective gene of Coccidioides immitis by cDELI.
Tekiel et al. [27] obtained 28 protective genes of Trypa-
nosoma cruzi from a trypomastigote cDNA expression
library. Huntley et al. [28] identified 26 protective genes
of Mycobacterium avium paratuberculosis. There are
several reasons why the number of protective genes iso-
lated using cDELI is often small. The following explana-
tions might answer this question. First, since the
genome of Eimeria spp. is estimated to be between 55
and 60 Mbp in size, encoding 8000–9000 genes (http://
www.genedb.org/Homepage/Etenella), it is very difficult
to include all genes in the cDNA library, and some
protective genes might be lost during the library con-
struction, such as two protective antigens AMA-1 and
IMP-1 described by Blake et al. [14]. Secondly, another
explanation may be the weakness of ELI approach. The
simultaneous expression of many antigens could lead to
antigenic competition. For example, some antigens are
known to be the focus of immune responses, while
others can induce immunological non-responsiveness
which could mask the effective antigens in cDELI [29].
The effective antigens also could be masked by the dilu-
tion effect during cDELI. For example, if one sub-library
contains 100 plasmids during cDELI, each individual
plasmid will be delivered in 1/100th of the maximal dose
of DNA and will therefore generate a weaker response
than if delivered by itself at the highest dose [23]. This
could also be due to the fact that the gene length prob-
ably alters the cloning/transformation efficiency. Some
longer transcripts may clone less efficiently than smaller
transcripts. Thirdly, we used ACI as a screening criter-
ion, a synthetic criterion including weight gain, survival
rate, oocysts output and lesion score. Since ACIs of
some clones/sub-libraries were very close to 160, one
possible way to increase the number of protective anti-
gens is to pick clones with a lower ACI and then test
them for the immunologic parameters.
In this study, we identified four novel protective anti-
gen genes (EmJS-1, EmRP, EmHP-1 and EmHP-2) and
two known antigen genes (EmSAG and EmCKRS).
EmJS-1 is a selR domain-containing protein of E. max-
ima whose function is unknown. Rhomboid-like protein
is involved in shedding adhesions from the surface of
several apicomplexan parasites during motility and host
cell entry by cleaving their substrates microneme pro-
teins within their transmembrane domains [30, 31].
However, rhomboid protein functions with different sub-
strate specificities [32]. In Toxoplasma gondii, TgROM1,
TgROM2 and TgROM5 cleaved the transmembrane
(TM) domain of Drosophila Spitz. TgROM2 cleaved the
TM domains of TgMIC2 and TgMIC12 [33]. TgROM4
participated in processing of surface adhesions including
TgMIC2, AMA1 and TgMIC3 [34]. In Eimeria tenella,
EtROM3 was involved in the cleavage of EtMIC4 [31].
The activity and substrate specificity of E. maxima
rhomboid (EmRP) has not been reported. Surface anti-
gen glycoproteins (SAGs) of E. tenella are implicated in
host-parasite interactions, where they are thought to be
involved in the initial attachment of the parasite to the
host [35]. However, the functions of these genes in E.
maxima remain unknown. Therefore, further researches
are needed to evaluate the functions of the six protective
antigens identified in this study.
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Conclusions
This study identified six protective genes of E. maxima
through cDNA expression library construction and
screening. Of the six protective genes, four are new and
include EmJS-1, EmRP, EmHP-1 and EmHP-2. The
remaining protective genes, EmSAG and EmCKRS, are
known. EmJS-1 is the selR domain-containing protein of
E. maxima whose function is unknown. EmHP-1 and
EmHP-2 are the hypothetical proteins of E. maxima and
EmRP and EmSAG are implicated in the invasion of the
parasite. Our results provide a cDNA expression library
for the further screening of T cell stimulating or inhibit-
ing antigens of E. maxima. Moreover, our data provided
six candidate protective antigens for developing new
vaccines against E. maxima.
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